HTA assessments on elmiron®:
  • Used as per licensed indication, only if:
    • the condition has not responded to an adequate trial of standard oral treatments
    • not offered in combination with bladder instillations
    • previous treatment with bladder instillations was not stopped due to lack of response
    • it is used in secondary care and
    • the Patient Access Scheme (PAS) is in place
  • Used as per licensed indication
  • The Patient Access Scheme (PAS) is in place
elmiron® Patient Access Scheme (PAS)